Form 4 for CL Colgate-Palmolive
Accepted 2023-09-13 00:00:00 ET · period of report 2023-09-11 · accession 0001225208-23-008898 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-09-13 | 2023-09-11 | CL | Daniels Jennifer | CLO, Sec | S - Sale+OE | $73.31 | -24.7K | 52.8K | -32% | -$1.81M |
| D | 2023-09-13 | 2023-09-11 | CL | Daniels Jennifer | CLO, Sec | M - OptEx | $73.00 | +24.7K | 77.5K | +47% | +$1.80M |
| D | 2023-09-13 | 2023-09-11 | CL | Daniels Jennifer | CLO, Sec | M - OptEx | $0.00 | -24.7K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-09-11 | S | D | 24,704 | $73.31 | 52,813 | D | — | — | (F3) Weighted average price, as these shares were sold in multiple transactions at prices ranging from $73.20 to $73.47, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 2 | Common | Common Stock | 2023-09-11 | M | A | 24,704 | $73.00 | 77,517 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2023-09-11 | M | D | 24,704 | $0.00 | 0 | D | $73.00 · — to 2023-09-25 | 24,704 Common Stock | (F4) Option became exercisable in one-third increments beginning on the first anniversary of the September 25, 2017 grant date. |